New ultrasound could catch prostate cancers MRI misses

NCT ID NCT07386171

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a high-resolution ultrasound technique, called micro-ultrasound, can find aggressive prostate cancers that standard MRI might miss. Researchers will enroll 90 men with low-risk prostate cancer who have negative or stable MRI results. Participants will get a micro-ultrasound exam, and if suspicious areas are seen, targeted biopsies will be taken. The goal is to see if this imaging method improves detection of clinically significant prostate cancer, potentially offering a more accessible and accurate diagnostic tool.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Micro-ultrasound imaging

What this could lead to

If successful, micro-ultrasound could become a reliable, real-time tool to catch aggressive prostate cancers that MRI misses, helping men avoid unnecessary biopsies or delayed treatment.

What could go wrong

This is a small, early-stage study (90 participants) testing a new imaging technique. It may not prove accurate enough to replace MRI, and results may not apply to all men with prostate cancer.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

prostate cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Jewish General Hospital

    Montreal, Quebec, H3T 1E2, Canada

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact